Liquid biopsy is a convenient, fast, non-invasive and reproducible sampling method that can
dynamically reflect the changes in tumor gene expression profile, and provide a robust basis …

Distant metastases harbor unique genomic characteristics not detectable in the
corresponding primary tumor of the same patient and metastases located at different sites …

The term 'liquid biopsy', introduced in 2013 in reference to the analysis of circulating tumour
cells (CTCs) in cancer patients, was extended to cell-free nucleic acids (cfNAs) circulating in …

Tissue biopsy is the standard diagnostic procedure for cancers and also provides a material
for genotyping, which can assist in the targeted therapies of cancers. However, tissue biopsy …

In recent years, the introduction of new molecular techniques in experimental and clinical
settings has allowed researchers and clinicians to propose circulating-tumor DNA (ctDNA) …

Liquid biopsy has been introduced as a new diagnostic concept predicated on the analysis
of circulating tumour cells (CTCs) or circulating tumour-derived factors, in particular, cell-free …

Cancer is one of the greatest threats facing our society, being the second leading cause of
death globally. Currents strategies for cancer diagnosis consist of the extraction of a solid …

Technological advancements in research on circulating biomarkers from patient derived
blood have enabled a less invasive means of diagnosing non-hematologic cancers …

A potential non-invasive technique for identifying and tracking cancer is a liquid biopsy. This
review article provides a comprehensive overview of the principles, applications, and …

Precision medicine refers to the choosing of targeted therapies based on genetic data. Due
to the increasing availability of data from large-scale tumor genome sequencing projects …